ClinicalTrials.Veeva

Menu

Carnitine Supplementation and Skeletal Muscle Mass (ROM)

G

Gdansk University of Physical Education and Sport

Status

Completed

Conditions

Muscle Loss

Treatments

Dietary Supplement: L-carnitine

Study type

Interventional

Funder types

Other

Identifiers

NCT05009641
2014/15/B/NZ7/00893
NCN_ROM

Details and patient eligibility

About

The primary aim of the current research project is to investigate the effect of carnitine supplementation on muscle strength and body composition.

A secondary aim of this project is to explore the effect of circulating trimethylamine N-oxide elevation, induced by carnitine supplementation on muscle strength and body composition.

Enrollment

24 patients

Sex

All

Ages

18 to 29 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • must be able to swallow tablets

Exclusion criteria

  • cardiovascular disease
  • liver disease
  • kidney disease
  • neuromuscular disease
  • gastrointestinal disorders (including stomach ulcers and erosions)
  • diabetes
  • other severe chronic diseases

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

24 participants in 3 patient groups

carnitine2
Experimental group
Description:
2000 mg L-carnitine per day for 24 weeks
Treatment:
Dietary Supplement: L-carnitine
carnitine
Active Comparator group
Description:
1000 mg L-carnitine per day for 24 weeks
Treatment:
Dietary Supplement: L-carnitine
control
No Intervention group
Description:
no supplementation

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems